Pathogenesis of Plasmodium falciparum malaria: The roles of parasite adhesion and antigenic variation

Cellular and Molecular Life Sciences

Volumn 59, Issue 2, 2002, Pages 258-271

  Beeson, J G ^a   Brown, G V ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adhesion; Antigenic variation; Cerebral malaria; Malaria; Pathogenesis; Placenta; Var genes

Indexed keywords

ANTIGEN; CHONDROITIN 4 SULFATE; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; MEMBRANE PROTEIN;

ANTIGENIC VARIATION; BRAIN MALARIA; ENDOTHELIUM CELL; ERYTHROCYTE; HOST PARASITE INTERACTION; IMMUNE RESPONSE; INFECTION; MALARIA FALCIPARUM; MULTIGENE FAMILY; PATHOGENESIS; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIGENIC VARIATION; CELL ADHESION; CELL ADHESION MOLECULES; ERYTHROCYTES; FEMALE; HOST-PARASITE RELATIONS; HUMANS; IMMUNOLOGIC FACTORS; MALARIA, FALCIPARUM; MODELS, BIOLOGICAL; PLASMODIUM FALCIPARUM; PREGNANCY;

PLASMODIUM FALCIPARUM;

EID: 0036176967     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8421-y     Document Type: Review

References (150)

1. World malaria situation
2. Severe and complicated malaria
3. Malaria-related anaemia
4. Deep breathing in children with severe malaria: Indicator of metabolic acidosis and poor outcome
5. An analysis of malaria in pregnancy in Africa
6. Epidemiology, malaria and pregnancy
7. Malaria-related maternal mortality in urban Mozambique
8. The pathology of human cerebral malaria
9. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: A pathological study
10. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration
11. Human cerebral malaria: A pathological study
12. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain
13. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration
14. Placental pathologic changes in malaria. A histologic and ultrastructural study
15. Plasmodium falciparum associated placental pathology: A light and electron microscopic and immunohistologic study
16. Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells
17. Cerebral malaria: The sequestration hypothesis
18. Severe falciparum malaria in children: Current understanding of pathophysiology and supportive treatment
19. Neurological sequelae of cerebral malaria in children
20. Clinical features and prognostic indicators in paediatric cerebral malaria: A study of 131 comatose Malawian children
21. Cognitive sequelae of severe malaria with impaired consciousness
22. The cytokine theory of human cerebral malaria
23. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
24. Tumor necrosis factor and disease severity in children with falciparum malaria
25. TNF concentration in fatal cerebral, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria
26. Why is the pathology of falciparum worse than that of vivax malaria?
27. Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression
28. Nitric oxide in cerebral malaria
29. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea
30. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites
31. Glycosylphosphatidylinositol toxin of Plasmodium upregulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction
32. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway
33. Acid-base status in paediatric Plasmodium falciparum malaria
34. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria
35. Indicators of life-threatening malaria in African children
36. The pathophysiology of malaria
37. Estimating sequestered parasite population dynamics in cerebral malaria
38. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria
39. Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells
40. Protection, pathogenesis and phenotypic plasticity in Plasmodium falciparum malaria
41. Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes
42. Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes
43. Human cerebral malaria: Association with erythrocyte rosetting and lack of anti-rosetting antibodies
44. Rosette formation in Plasmodium falciparum isolates and ami-rosette activity of sera from Gambians with cerebral or uncomplicated malaria
45. Plasmodium falciparum rosetting is associated with malaria severity in Kenya
46. Rosette formation of Plasmodium falciparum-infected erythrocytes from patients with acute malaria
47. Human cerebral malaria: Lack of significant association between erythrocyte rosetting and disease severity
48. Disruption of erythrocyte rosettes and agglutination of erythrocytes infected with Plasmodium falciparurn by the sera of Papua New Guineans
49. Rapid switching to multiple antigenic and adhesive phenotypes in malaria
50. Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria
51. Autoagglutination of malaria-infected red blood cells and malaria severity
52. Ultrastructural analysis of fresh Plasmodium falciparum-infected erythrocytes and their cytoadherence to human leukocytes
53. Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum
54. Alteration in the rheologic properties of Plasmodium kmowlesi-infected red cells. A possible mechanism for capillary obstruction
55. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties
56. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta
57. Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A
58. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria
59. Parasite adhesion and immune evasion in placental malaria
60. Receptor-specific adhesion and clinical disease in Plasmodium falciparum
61. Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria
62. Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells
63. Visualization of Plasmodium falciparum-endothelium interactions in human microvasculature: Mimicry of leukocyte recruitment
64. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor
65. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes
66. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes
67. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: Differential adhesion of infected erythrocytes to CD36 and ICAM-1
68. Malaria susceptibility and CD36 mutation
69. A non-sense mutation in Cd36 gene is associated with protection from severe malaria
70. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: A role for CD36 in malarial clearance
71. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells
72. Intercellular adhesion molecule-1 is an endothelial cell adhesion molecule for Plasmodium falciparum
73. The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from the LFA-1 binding site
74. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya
75. Association of the ICAM-1 Kilifi mutation with protection against severe malaria in Lambarene, Gabon
76. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes
77. Adhesion of malaria-infected red blood cells to chondroitin sulfate A under flow conditions
78. Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells
79. Inhibition of binding of malaria-infected erythrocytes by a tetradecasaccharide fraction from chondroitin sulfate A
80. Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta
81. Plasmodium falciparum-infected erythrocytes adhere to the proteoglycan thrombomodulin in static and flow-based systems
82. Chondroitin sulfate of thrombomodulin is an adhesion receptor for Plasmodium falciparum-infected erythrocytes
83. Regional distribution of thrombomodulin in human brain
84. Cytoadherence characteristics of Plasmodium falciparum isolates from Thailand: Evidence for chondroitin sulfate A as a cytoadherence receptor
85. Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model
86. Immunohistological and biochemical evidence for a role for hyaluronic acid in the growth and development of the placenta
87. Cytochemical studies of the maternal surface of the syncytiotrophoblast of human early and term placenta
88. Ultrastrucrural localization of glycosaminoglycans in human term placenta
89. Inhibition of adhesion of Plasmodium falciparum-infected erythrocytes by structurally defined hyaluronic acid dodecasaccharides
90. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion
91. Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum
92. Disruption of Plasmodium-falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity
93. Sulfated glycoconjugates as disrupters of Plasmodium falciparum erythrocyte rosettes
94. Plasmodium falciparum: Molecular background to strain-specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates
95. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1
96. Mapping of the region of complement receptor 1 (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates
97. Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions
98. Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting
99. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: Roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1
100. Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions
101. Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence
102. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes
103. 3 on human microvascular endothelial cells
104. Receptor specificity of clinical Plasmodium falciparum isolates: Nonadherence to cell-bound E-selectin and vascular cell adhesion molecule-1
105. Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: Conserved function with variant sequence
106. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by PfEMP1
107. Identification of a Plasmodium-falciparum intercellular adhesion molecule-1 binding domain: A parasite adhesion trait implicated in cerebral malaria
108. Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress
109. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes
110. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors
111. Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family
112. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes
113. A recombinant peptide based on PfEMP1 blocks and reverses adhesion of malaria-infected red blood cells to CD36 under flow
114. Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain
115. Identification of glycosaminoglycan binding domains in Plasmodium falciparum erythrocyte membrane protein 1 of a chondroitin sulfate A-adherent parasite
116. Plasmodium falciparum: Cloned and expressed CIDR domains of PfEMP1 bind to chondroitin sulfate A
117. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: A receptor for human placental infection
118. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1
119. The Duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding
120. Modifications in the CD36 binding domain of the Plasmodium falciparum variant antigen are responsible for the inability of chondroitin sulfate A adherent parasites to bind CD36
121. Sequestrin, a CD36 recognition protein on Hasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies
122. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum
123. Plasmodium falciparum: Thrombospondin mediates parasitized erythrocyte band 3-related adhesin binding
124. Genes necessary for expression of a virulence determinant and for transmission of Plasmodium falciparum are located on a 0.3-megabase region of chromosome 9
125. clag9: A cytoadherence gene in Plasmodium falciparum essential for binding of parasitized erythrocytes to CD36
126. Antigenic variation in Plasmodium falciparum
127. Immunity to malaria: Antigenic variation in chronic infection of Plasmodium knowlesi
128. Antigenic variation of cloned Plasmodium fragile in its natural host Macaca sinica. Sequential appearance of successive variant antigenic types
129. Plasmodium chabaudi: Relationship between the occurrence ofrecrudescent parasitaemias in mice and the effective levels of acquired immunity
130. Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum
131. Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes
132. Cytoadherence by Plasmodium falciparum-infected erythrocytes is correlated with the expression of a family of variable proteins on infected erythrocytes
133. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes
134. Developmental selection of var gene expression in Plasmodium falciparum
135. Antigenic variation in malaria: In situ switching, relaxed and mutally exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum
136. stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens
137. Small, clonally variant antigens expressed on the surface of Plasmodium falciparum-infected erythrocytes are encoded by the rif gene family and are targets of human immune responses
138. Rifins: A second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum
139. Antigens induced on erythrocytes by P. falciparum: Expression of diverse and conserved determinants
140. Diversity of agglutinating phenotype, cytoadherence, and rosette-forming characteristics of Plasmodium falciparum isolates from Papua New Guinean children
141. Diversity of antigens expressed on the surface of the erythrocytes infected with mature Plasmodium falciparum parasites in Papua New Guinea
142. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria
143. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection
144. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections
145. Agglutination of Plasmodium falciparum-infected erythrocytes from East and West African isolates by human sera from distant geographic regions
146. The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes
147. The placenta in malaria: Mechanisms of infection, disease and fetal morbidity
148. Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta
149. Maternal antibodies block malaria
150. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A